Research finds that 87% of consumers choose generic drugs

According to recent research, nearly nine out ofstated that more than 70 brand name drugs,
10 clients decide to substitute common brandincluding 19 blockbusters, are losing their patent
name drugs by their generic versions within a fewprotection within the next five years - with total
weeks of when these cheapest drugs becomeyearly sales of $45 billion. If Medco's study reveals
obtainable. The researchers analyzed four drugs:a long-term trend, in the coming years
Allegra, Arava, Amaryl and Zithromax. In theconsumers, employers and insurance companies
second half of 2005, each of these drugs run outwill save billions of dollars in prescription drug -
of patent protection. Their generic equivalentsSmith said. The data met with enthusiastic
were bought instead at an average factor of 87reaction from consumer groups. "We hope the
percent within 30 days of the equivalent's deliverytrend continues. It's good for consumers,"
at pharmacies. The research was organized byconfessed Bill Vaughan, senior policy analyst for an
Medco Health Solutions Inc. based in Frankin Lakes,advocacy group, Consumer Union, based in
which is the biggest drug benefit managementWashington, D.C. Vaughan mentioned that past
company in U.S. The company bargains for lowfears concerning the effectiveness and safety of
prices of prescription drug on behalf of itsgeneric drugs have apparently started to fade
customers. According to the study, Zithromax,away as society has become more concerned
the blockbuster of Pfizer Inc. with its annual salesabout rapid increase of health-care costs. "The
of $1.85 billion was rapidly substituted atFDA approves these generic drugs because they
pharmacies by generic equivalent at a 90 percenthave been determined just as safe and effective
rate just after it lost its patent protection inas their brand name counterparts, but you pay a
November. The study authors mentioned thefraction of the price," Vaughan stated. "We think
substitution of Zithromax, an antibiotic forthis is very positive and can save consumers
respiratory infections, as evidence that more andliterally billions of dollars in the next few years." At
more doctors prescribe generic versions of brandthe same time, large pharmaceutical companies
name drugs more easily, even if it is abouthave claimed that their brand name drugs will not
so-called acute care drugs, such as Zithromax.be substituted by knockoffs as insurers and
"The really good news is that these four genericdoctors realize that the brand name drugs
medications are just the start. With a number ofguarantee better care and in consequence - save
popular medications expected to move off patentmoney. Hank McKinnell, Pfizer Chairman used that
in the next several years, we should seeargument during last session with analysts in New
substantial prescription drug costs savings" -York. "If you don't like the high cost of health
stated a Medco senior vice president, Dr. Glencare, try the high cost of sickness," McKinnell
Stettin. A spokeswoman at Medco, Ann Smithadvised.